IL325591A - צורה גבישית של בקסדרוסטאט ושיטה להכנתו ושימוש בו - Google Patents

צורה גבישית של בקסדרוסטאט ושיטה להכנתו ושימוש בו

Info

Publication number
IL325591A
IL325591A IL325591A IL32559125A IL325591A IL 325591 A IL325591 A IL 325591A IL 325591 A IL325591 A IL 325591A IL 32559125 A IL32559125 A IL 32559125A IL 325591 A IL325591 A IL 325591A
Authority
IL
Israel
Prior art keywords
baxdrostat
preparation
crystal form
method therefor
therefor
Prior art date
Application number
IL325591A
Other languages
English (en)
Original Assignee
Crystal Pharmaceutical Suzhou Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crystal Pharmaceutical Suzhou Co Ltd filed Critical Crystal Pharmaceutical Suzhou Co Ltd
Publication of IL325591A publication Critical patent/IL325591A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL325591A 2023-06-29 2025-12-24 צורה גבישית של בקסדרוסטאט ושיטה להכנתו ושימוש בו IL325591A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202310782860 2023-06-29
PCT/CN2024/102325 WO2025002335A1 (zh) 2023-06-29 2024-06-28 Baxdrostat的晶型及其制备方法和用途

Publications (1)

Publication Number Publication Date
IL325591A true IL325591A (he) 2026-02-01

Family

ID=93937580

Family Applications (1)

Application Number Title Priority Date Filing Date
IL325591A IL325591A (he) 2023-06-29 2025-12-24 צורה גבישית של בקסדרוסטאט ושיטה להכנתו ושימוש בו

Country Status (8)

Country Link
US (1) US20260125358A1 (he)
EP (1) EP4737447A1 (he)
KR (1) KR20260027280A (he)
CN (1) CN121399108A (he)
AU (1) AU2024310688A1 (he)
IL (1) IL325591A (he)
MX (1) MX2025015804A (he)
WO (1) WO2025002335A1 (he)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9353081B2 (en) * 2011-09-23 2016-05-31 Hoffmann-La Roche Inc. Bicyclic dihydroquinoline-2-one derivatives
IL309428A (he) * 2021-06-24 2024-02-01 Cincor Pharma Inc שיטות שימוש במעכבי סינתז אלדוסטרון

Also Published As

Publication number Publication date
KR20260027280A (ko) 2026-02-27
MX2025015804A (es) 2026-04-01
CN121399108A (zh) 2026-01-23
AU2024310688A1 (en) 2026-01-29
EP4737447A1 (en) 2026-05-06
US20260125358A1 (en) 2026-05-07
WO2025002335A1 (zh) 2025-01-02

Similar Documents

Publication Publication Date Title
EP3912976A4 (en) SALT OF AN EGFR INHIBITOR, CRYSTALLINE FORM AND METHOD FOR PREPARING THEREOF
EP4059926A4 (en) CRYSTALLINE FORM OF TAFAMIDIS AND PROCESS FOR PRODUCTION AND USE THEREOF
GB2611937B (en) Eyewear, method of manufacture and use thereof
ZA202107810B (en) Crystal form of phosphodiesterase inhibitor, preparation method therefor and use thereof
EP4219451A4 (en) CRYSTALLINE FORM OF PYRIDINYLPHENYL COMPOUND AND PREPARATION METHOD THEREOF
PL4062912T3 (pl) Półuwodniony monokryształ utidelonu oraz sposób jego wytwarzania i zastosowanie
IL311106A (he) צורות מוצקות של מעכבי bcl-2, שיטת ההכנה והשימוש בהם
EP3971170A4 (en) HIGH PURITY THERMOSTABLE CRYSTAL FORM OF SUBSTITUTED 3-ISOXAZOLIDINONE COMPOUND, PROCESS FOR THEIR PRODUCTION AND ITS USE
EP4222148A4 (en) CRYSTALLINE FORM OF TEGAVIVINT, MANUFACTURING METHOD AND USE THEREOF
IL326072A (he) צורה גבישית של בזוקלסטיניב, שיטה להכנתה והשימוש בה
GB202119051D0 (en) Wingsail and method of use
EP4269408A4 (en) CRYSTAL FORM OF A COMPOUND AND METHOD OF PREPARING IT AND USE THEREOF
EP3971175A4 (en) CRYSTAL FORM OF A QUINAZOLINONE COMPOUND AND PROCESS FOR THEIR PRODUCTION
EP3985009A4 (en) B crystal form of tetrahydrothienopyridine compound, preparation method therefor, composition and application
EP3736273A4 (en) NEW ACALABRUTINIB CRYSTAL FORM AND THE MANUFACTURING METHOD AND USE OF IT
CA3299494A1 (en) Crystal form of bezuclastinib, preparation method therefor and use thereof
CA3297597A1 (en) Crystal form of baxdrostat, and preparation method therefor and use thereof
HK40111859A (en) Crystal form of lanifibranor, preparation method therefor, and use thereof
HK40109973A (en) Crystal form of tolebrutinib, preparation method therefor and use thereof
HK40110981A (en) Crystal form of tolebrutinib, preparation method therefor and use thereof
HK40118699A (zh) 一种nk3r拮抗剂的晶型及其制备方法和应用
IL286834A (he) צורת גביש של טטראמתילפיראזין ניטרון, שיטת הכנה ושימוש בה
HK40111131A (en) New crystal form of compound, and preparation method therefor and use thereof
IL326381A (he) צורה גבישית vi של תרכובת אקרילאמיד ושיטה להכנתה ושימוש בה
SG11202112354SA (en) Crystal form of pyridone derivative, and preparation method and use thereof